Phosphorylated p120-catenin expression has predictive value for oral cancer progression

Journal of Clinical Pathology

Volumn 65, Issue 4, 2012, Pages 315-319

  Ma, Li Wei ^a   Zhou, Zeng Tong ^a   He, Qing Bo ^a   Jiang, Wei Wen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CATENIN; PROTEIN P120;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CYTOPLASM; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MOUTH LESION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CATENINS; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PHOSPHORYLATION; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862815600     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2011-200516     Document Type: Article

References (28)

1. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin 2002;52:195-215.
2. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009;45:309-16.
3. Ganly I, Patel S, Shah J. Early stage squamous cell cancer of the oral tongue - clinicopathologic features affecting outcome. Cancer 2012;118:101-11.
4. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol 2010;46:423-25.
5. Pitiyage G, Tilakaratne WM, Tavassoli M, et al. Molecular markers in oral epithelial dysplasia: review. J Oral Pathol Med 2009;38:737-52.
6. Smith J, Rattay T, McConkey C, et al. Biomarkers in dysplasia of the oral cavity: a systematic review. Oral Oncol 2009;45:647-53.
7. Mehanna HM, Rattay T, Smith J, et al. Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis. Head Neck 2009;31:1600-9.
8. Nankivell P, Mehanna H. Oral dysplasia: biomarkers, treatment, and follow-up. Curr Oncol Rep 2011;13:145-52.
9. Reynolds AB. p120-catenin: past and present. Biochim Biophys Acta 2007;1773:2-7.
10. van Hengel J, van Roy F. Diverse functions of p120ctn in tumors. Biochim Biophys Acta 2007;1773:78-88.
11. Shibamoto S, Hayakawa M, Takeuchi K, et al. Association of p120, a tyrosine kinase substrate, with E-cadherin/catenin complexes. J Cell Biol 1995;128:949-57.
12. Alemà S, Salvatore AM. p120 catenin and phosphorylation: mechanisms and traits of an unresolved issue. Biochim Biophys Acta 2007;1773:47-58.
13. Zhang PX, Wang Y, Liu Y, et al. p120-catenin isoform 3 regulates subcellular localization of Kaiso and promotes invasion in lung cancer cells via a phosphorylationdependent mechanism. Int J Oncol 2011;38:1625-35.
14. Macpherson IR, Hooper S, Serrels A, et al. p120-catenin is required for the collective invasion of squamous cell carcinoma cells via a phosphorylation-independent mechanism. Oncogene 2007;26:5214-28. (Pubitemid 47237629)
15. Mariner DJ, Davis MA, Reynolds AB. EGFR signaling to p120-catenin through phosphorylation at Y228. J Cell Sci 2004;117:1339-50. (Pubitemid 38559812)
16. Taoudi Benchekroun M, Saintigny P, Thomas SM, et al. Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer. Cancer Prev Res 2010;3:800-9.
17. Lo Muzio L, Lo Russo L, Falaschini S, et al. beta- and gamma-catenin expression in oral dysplasia. Oral Oncol 2009;45:501-4.
18. Chung Y, Lam AK, Luk JM, et al. Altered E-cadherin expression and p120 catenin localization in esophageal squamous cell carcinoma. Ann Surg Oncol 2007;14:3260-7. (Pubitemid 47594279)
19. Jawhari AU, Noda M, Pignatelli M, et al. Up-regulated cytoplasmic expression, with reduced membranous distribution, of the src substrate p120(ctn) in gastric carcinoma. J Pathol 1999;189:180-5. (Pubitemid 29448910)
20. Lo Muzio L, Pannone G, Staibano S, et al. p120(cat) Delocalization in cell lines of oral cancer. Oral Oncol 2002;38:64-72. (Pubitemid 34076574)
21. Lingen MW, Pinto A, Mendes RA, et al. Genetics/epigenetics of oral premalignancy: current status and future research. Oral Dis 2011;17(Suppl 1):7-22.
22. Wu RQ, Zhao XF, Wang ZY, et al. Novel molecular events in oral carcinogenesis via integrative approaches. J Dent Res 2011;90:561-72.
23. Torres-Rendon A, Roy S, Craig GT, et al. Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas. Br J Cancer 2009;100:1128-34.
24. Montebugnoli L, Cervellati F, Cocchi R, et al. Immunohistochemical expression of p16(INK4A) protein as a helpful marker of a subset of potentially malignant oral epithelial lesions: study on a series with long-term follow-up. Histopathology 2010;57:528-34.
25. Liu W, Wang YF, Zhou HW, et al. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. BMC Cancer 2010;10:685.
26. Jeong WJ, Paik JH, Cho SW, et al. Excisional biopsy for management of lateral tongue leukoplakia. J Oral Pathol Med. Published Online First: 12 November 2011. doi:10.1111/j.1600-0714
27. Ogbureke KU, Abdelsayed RA, Kushner H, et al. Two members of the SIBLING family of proteins, DSPP and BSP, may predict the transition of oral epithelial dysplasia to oral squamous cell carcinoma. Cancer 2010;116:1709-17.
28. Liu W, Feng JQ, Shen XM, et al. Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study. Cancer 2012;118:1693-700.